BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28248808)

  • 1. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M; Liebers J; Maynard R
    J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home inotropic therapy in children.
    Berg AM; Snell L; Mahle WT
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
    J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
    Gorski LA
    Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
    Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
    J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
    Cesario D; Clark J; Maisel A
    Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral inotropic support for advanced congestive heart failure.
    Leier CV; Binkley PF
    Prog Cardiovasc Dis; 1998; 41(3):207-24. PubMed ID: 9872607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
    Cusick DA; Pfeifer PB; Quigg RJ
    Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a brief case series.
    Albrecht CA; Giesler GM; Kar B; Hariharan R; Delgado RM
    Tex Heart Inst J; 2005; 32(2):220-3. PubMed ID: 16107121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy Support of a Pediatric Patient Receiving Milrinone at Home.
    Xue A; Dersch-Mills D; Tsang C; Greenway SC
    Can J Hosp Pharm; 2016; 69(5):415-419. PubMed ID: 27826160
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous milrinone in cardiac surgery.
    Levy JH; Bailey JM; Deeb GM
    Ann Thorac Surg; 2002 Jan; 73(1):325-30. PubMed ID: 11834047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure.
    Price JF; Towbin JA; Dreyer WJ; Moffett BS; Kertesz NJ; Clunie SK; Denfield SW
    J Card Fail; 2006 Mar; 12(2):139-43. PubMed ID: 16520263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous inotropic therapy in the home.
    McCloskey WW
    Am J Health Syst Pharm; 1998 May; 55(9):930-5; quiz 953-4. PubMed ID: 9588252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates.
    Canver CC; Chanda J
    Ann Thorac Surg; 2000 Jun; 69(6):1823-6. PubMed ID: 10892930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure.
    Takeno M; Takagi S; Sakuragi S; Suzuki S; Tsutsumi Y; Nonogi H; Goto Y
    Heart Vessels; 2002 Nov; 17(1):42-4. PubMed ID: 12434201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.